loadpatents
name:-0.015388011932373
name:-0.0056140422821045
name:-0.0070321559906006
Silverman; Adam P. Patent Filings

Silverman; Adam P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Silverman; Adam P..The latest application filed is for "anti-trem2 antibodies and methods of use thereof".

Company Profile
9.7.18
  • Silverman; Adam P. - South San Francisco CA
  • Silverman; Adam P. - San Carlos CA
  • Silverman; Adam P. - Redwood City CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-Tau antibodies and methods of use thereof
Grant 11,370,832 - Chen , et al. June 28, 2
2022-06-28
Anti-trem2 Antibodies And Methods Of Use Thereof
App 20220177576 - Dennis; Mark S. ;   et al.
2022-06-09
Engineered Bispecific Proteins
App 20220017634 - Kannan; Gunasekaran ;   et al.
2022-01-20
Anti-ApoE antibodies
Grant 11,124,562 - Holtzman , et al. September 21, 2
2021-09-21
Anti-TREM2 antibodies and methods of use thereof
Grant 11,124,567 - Dennis , et al. September 21, 2
2021-09-21
Human Alpha-galactosidase Variants
App 20210269787 - Hallows; William Casey ;   et al.
2021-09-02
Anti-trem2 Antibodies And Methods Of Use Thereof
App 20210214438 - Dennis; Mark S. ;   et al.
2021-07-15
Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes
App 20210198640 - Astarita; Giuseppe ;   et al.
2021-07-01
Engineered Acid Alpha-glucosidase Variants
App 20210189365 - Hallows; William Casey ;   et al.
2021-06-24
Transferrin Receptor-binding Polypeptides And Uses Thereof
App 20210130485 - Dennis; Mark S. ;   et al.
2021-05-06
Anti-bace1 Antibodies And Methods Of Use Thereof
App 20210070881 - Dennis; Mark S. ;   et al.
2021-03-11
Fusion proteins comprising enzyme replacement therapy enzymes
Grant 10,870,837 - Henry , et al. December 22, 2
2020-12-22
Engineered Transferrin Receptor Binding Polypeptides
App 20200369746 - Chen; Xiaocheng ;   et al.
2020-11-26
Affinity-based Methods For Using Transferrin Receptor-binding Proteins
App 20200289627 - Dennis; Mark S. ;   et al.
2020-09-17
Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes
App 20200277584 - ASTARITA; Giuseppe ;   et al.
2020-09-03
Engineered Transferrin Receptor Binding Polypeptides
App 20200223935 - Chen; Xiaocheng ;   et al.
2020-07-16
Anti-tau Antibodies And Methods Of Use Thereof
App 20200216522 - Chen; Xiaocheng ;   et al.
2020-07-09
Transferrin Receptor Transgenic Models
App 20190274291 - Dennis; Mark S. ;   et al.
2019-09-12
Anti-apoe Antibodies
App 20190270794 - Holtzman; David ;   et al.
2019-09-05
Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes
App 20190249155 - Henry; Anastasia ;   et al.
2019-08-15
Transferrin receptor transgenic models
Grant 10,143,187 - Dennis , et al. De
2018-12-04
Transferrin Receptor Transgenic Models
App 20180235195 - Dennis; Mark S. ;   et al.
2018-08-23
Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use
Grant 8,778,888 - Cochran , et al. July 15, 2
2014-07-15
CYSTINE KNOT PEPTIDES BINDING TO ALPHA IIb BETA 3 INTEGRINS AND METHODS OF USE
App 20110136740 - Cochran; Jennifer R. ;   et al.
2011-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed